gemfibrozil has been researched along with Allergic Encephalomyelitis in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The present study underlines the importance of gemfibrozil, a lipid-lowering drug and an activator of peroxisome proliferator-activated receptor-alpha (PPAR-alpha), in inhibiting the disease process of adoptively transferred experimental allergic encephalomyelitis (EAE), an animal model of relapsing-remitting multiple sclerosis." | 3.74 | Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha. ( Dasgupta, S; Hartley, DM; Jana, M; Pahan, K; Roy, A, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (75.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gocke, AR | 1 |
| Hussain, RZ | 2 |
| Yang, Y | 1 |
| Peng, H | 1 |
| Weiner, J | 1 |
| Ben, LH | 1 |
| Drew, PD | 2 |
| Stuve, O | 1 |
| Lovett-Racke, AE | 2 |
| Racke, MK | 2 |
| Jana, M | 2 |
| Mondal, S | 1 |
| Gonzalez, FJ | 1 |
| Pahan, K | 2 |
| Northrop, S | 1 |
| Choy, J | 1 |
| Rocchini, A | 1 |
| Matthes, L | 1 |
| Chavis, JA | 1 |
| Diab, A | 1 |
| Dasgupta, S | 1 |
| Roy, A | 1 |
| Hartley, DM | 1 |
1 trial available for gemfibrozil and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Gemfibrozil, a lipid-lowering drug, increases myelin genes in human oligodendrocytes via peroxisome proliferator-activated receptor-β.
Topics: Animals; Cells, Cultured; Demyelinating Diseases; Encephalomyelitis, Autoimmune, Experimental; Gemfi | 2012 |
3 other studies available for gemfibrozil and Allergic Encephalomyelitis
| Article | Year |
|---|---|
Transcriptional modulation of the immune response by peroxisome proliferator-activated receptor-{alpha} agonists in autoimmune disease.
Topics: Animals; Blotting, Western; Cytokines; Encephalomyelitis, Autoimmune, Experimental; Enzyme-Linked Im | 2009 |
Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease.
Topics: Animals; Cell Line; Cell Line, Transformed; Cell Survival; Cells, Cultured; Cytokines; Dose-Response | 2004 |
Gemfibrozil ameliorates relapsing-remitting experimental autoimmune encephalomyelitis independent of peroxisome proliferator-activated receptor-alpha.
Topics: Animals; Encephalomyelitis, Autoimmune, Experimental; Female; GATA3 Transcription Factor; Gemfibrozi | 2007 |